We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck.
- Authors
Kiyota, Naomi; Tahara, Makoto; Homma, Akihiro
- Abstract
Surgery remains a foundation of treatment for locally advanced squamous cell carcinoma of the head and neck. For postoperative patients at high risk of recurrence, however, surgery by itself is not enough, and improvement in survival requires postoperative treatment. Unlike the case with most other malignancies, the standard postoperative treatment for locally advanced squamous cell carcinoma of the head and neck patients with high-risk factors for recurrence is radiotherapy or chemoradiotherapy with cisplatin. However, chemoradiotherapy with cisplatin at a dose of 100 mg/m2 once every 3 weeks has raised discussion over insufficient cisplatin delivery due to high-dose-related toxicity. As a possible solution, a recent randomized trial of the JCOG1008 has proved the non-inferiority of postoperative chemoradiotherapy with weekly cisplatin at a dose of 40 mg/m2 to 3-weekly cisplatin in terms of overall survival. Here, this review article focuses on current evidence and future perspectives of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck.
- Publication
Japanese Journal of Clinical Oncology, 2024, Vol 54, Issue 6, p613
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyae029